Day: February 24, 2026

Professional standing inside a regulated pharmaceutical cleanroom, illustrating contamination control in drug manufacturing, GMP quality management system oversight, facility design and equipment qualification, and regulatory inspection readiness.

WHO GMP in 2026: Inspection Readiness and Compliance Expectations

February 24, 2026

This article explains how global pharmaceutical GMP standards are applied during inspections, why operational gaps persist despite formal compliance, and how quality systems, contamination control, and risk-based execution shape regulatory inspection readiness across manufacturing operations.

Audit Observation in Pharma (2026 guide): Meaning, Types, and GMP Classification

February 24, 2026

Audit observations help pharma teams identify GMP gaps before they become bigger failures. When teams classify findings correctly, they prioritize CAPA actions faster, justify risk decisions clearly, and improve inspection readiness through stronger evidence, ownership, and effectiveness checks across operations.

More features

More features

Day: February 24, 2026

WHO GMP in 2026: Inspection Readiness and Compliance Expectations

Audit Observation in Pharma (2026 guide): Meaning, Types, and GMP Classification

News

Blog

Glossary

FAQ